|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/564 | |
| G01N 33/574 | |||
| G01N 33/74 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3102943 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15702275.7 |
| Europos patento paraiškos padavimo data | 2015-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/052188 |
| Data | 2015-02-03 |
| (87) | Numeris | WO 2015/117955 |
| Data | 2015-08-13 |
| (30) | Numeris | Data | Šalis |
| 14153825 | 2014-02-04 | EP |
| (72) |
HEIDECKE, Harald, DE
SCHULZE-FORSTER, Kai, DE
|
| (73) |
CellTrend GmbH,
Im Biotechnologiepark, 14943 Luckenwalde,
DE
|
| (54) | DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST VASCULAR ENDOTHELIALGROWTH FACTOR RECEPTOR (VEGFR) |
| DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST VASCULAR ENDOTHELIALGROWTH FACTOR RECEPTOR (VEGFR) |